Gilead Sciences Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
FTC weighs in on reverse-payment generic delay case involving Gilead, Teva
The Federal Trade Commission has filed an amicus curiae brief in a case being heard in a U.S. appellate court involving an ...
FiercePharma1d
Gilead dominates Asian patient groups' drugmaker reputation rankings
Gilead Sciences has come from nowhere to dominate lists of the drugmakers with the best reputations in Asia, claiming the top ...
Gilead Sciences Inc. stock outperforms competitors despite losses on the day
The stock's fall snapped a four-day winning streak.
Investor's Business Daily on MSN3d
AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug
AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast ...
bovnews2d
Gilead Sciences, Inc. (GILD) Posted 3.79% Profit Margin Last Year—Can It Hold Up?
Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $83.99 which represents a slight increase of $0.05 or 0.06% from the prior close of $83.94. The stock opened at $84.25 and ...
Gilead’s biannual HIV shot reduced risk of infections by 96 percent, company says
Drugmaker Gilead Science announced Thursday that its biannual injections to prevent against HIV had slashed the risk of ...
FiercePharma7d
Gilead's Kite exits China cell therapy joint venture with Fosun Pharma
Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ)
Analysts fell to the sidelines weighing in on Gilead Sciences (GILD – Research Report) and Johnson & Johnson (JNJ – Research Report) with ...
ENDPOINTS NEWS6d
Gilead­'s Kite un­cou­ples from Fo­s­un in Chi­na as Yescar­ta faces cov­er­age ob­sta­cles
Gilead’s Kite Pharma is separating from its cell therapy joint venture with Fosun Pharma in China, handing Fosun the reins ...
Gilead Sciences Unusual Options Activity For September 20
Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...
Morrow County Sentinel6h
Mount Gilead boys’ XC wins at Fredericktown
Mount Gilead won the boys’ race at Tuesday’s Fredericktown Invitational, scoring 40 points to lead the 26-team field.